Skip to content

Sexuality After Reduction Mammaplasty

Sexuality and Depression Predictors Among Breast Hypertrophy Women Undergoing Reduction Mammaplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01020422
Enrollment
60
Registered
2009-11-25
Start date
2008-07-31
Completion date
2011-09-30
Last updated
2019-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Sexual Function

Keywords

breast hypertrophy, mammaplasty, sexuality, depression

Brief summary

The aim of this study is to determine the impact of reduction mammaplasty on sexuality and depression predictors in women with macromastia.

Detailed description

Breast hypertrophy is a common condition among women. Reduction mammaplasty is an effective and well established procedure performed for the relief discomfort associated with breast hypertrophy. Female breasts play an important role in sexuality, thus, the main purpose of this study is to determine whether reduction mammaplasty could influence sexual function and depression predictors on women with breast hypertrophy.

Interventions

Sexual function of patients undergoing reduction mammaplasty will be assessed by the Female Sexual Function Index (FSFI) preoperatively and 3 and 6 months postoperatively.

Sponsors

Universidade do Vale do Sapucai
CollaboratorOTHER
Daniela Francescato Veiga
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* breast hypertrophy * candidate to reduction mammaplasty * healthy volunteer with normal volume breasts (control group) * body mass index under 30Kg/m2

Exclusion criteria

* pregnancy, delivery or breast feeding during the last 12 months * body mass index over 30Kg/m2 * breast cancer history * previous breast surgery * hard smoking

Design outcomes

Primary

MeasureTime frameDescription
Sexual function6 monthsSexual function will be assessed by the Female Sexual Function Index (FSFI), pre and 6 months postoperatively.

Secondary

MeasureTime frameDescription
depression predictors6 monthsDepression predictors will me assessed by the Beck Depression Inventory (BDI) pre- and 6 months postoperatively.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026